10th Biennial Helene Harris Memorial Trust meeting.
Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.
Balkwill
Frances R
FR
Barts and The London Queen Mary's School of Medicine and Dentistry, UK.
Ashworth
Alan
A
Bast
Robert C
RC
Berek
Jonathon S
JS
Boyd
Jeff
J
Disis
Mary L
ML
Gabra
Hani
H
Gore
Martin E
ME
Hamilton
Thomas C
TC
Jacobs
Ian J
IJ
Kaye
Stan B
SB
Kohn
Elise C
EC
Mills
Gordon B
GB
Urban
Nicole D
ND
D000818:Animals; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*